Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Tang, Dean G  [Clear All Filters]
2015
Li Q, Rycaj K, Chen X, Tang DG. Cancer stem cells and cell size: A causal link?. Semin Cancer Biol. 2015.
Rycaj K, Tang DG. Cell-of-Origin of Cancer versus Cancer Stem Cells: Assays and Interpretations. Cancer Res. 2015.
Bilen MAsim, Lin S-H, Tang DG, Parikh K, Lee M-H, Yeung S-CJ, Tu S-M. Maintenance Therapy Containing Metformin and/or Zyflamend for Advanced Prostate Cancer: A Case Series. Case Rep Oncol Med. 2015;2015:471861.
2016
Chen X, Li Q, Liu X, Liu C, Liu R, Rycaj K, Zhang D, Liu B, Jeter C, Calhoun-Davis T, et al. Defining a population of stem-like human prostate cancer cells that can generate and propagate castration-resistant prostate cancer (CRPC). Clin Cancer Res. 2016.
Rycaj K, Cho EJeong, Liu X, Chao H-P, Liu B, Li Q, Devkota AK, Zhang D, Chen X, Moore J, et al. Longitudinal tracking of subpopulation dynamics and molecular changes during LNCaP cell castration and identification of inhibitors that could target the PSA-/lo castration-resistant cells. Oncotarget. 2016.
2019
Davis JE, Kirk J, Ji Y, Tang DG. Tumor Dormancy and Slow-Cycling Cancer Cells. Adv Exp Med Biol. 2019;1164:199-206.
2021
Jamroze A, Chatta G, Tang DG. Androgen receptor (AR) heterogeneity in prostate cancer and therapy resistance. Cancer Lett. 2021.
Ji Y, Kumar R, Ghokale A, Chao H-P, Rycaj K, Chen X, Li Q, Tang DG. LRIG1, a regulator of stem cell quiescence and a pleiotropic feedback tumor suppressor. Semin Cancer Biol. 2021.
Basu S, Dong Y, Kumar R, Jeter C, Tang DG. Slow-Cycling (Dormant) Cancer Cells in Therapy Resistance, Cancer Relapse and Metastasis. Semin Cancer Biol. 2021.